Collection and Storage of Tissue Samples for Solid Tumors

This study is collecting and storing tissue and blood samples from patients who are having surgery for suspected solid tumors (growths that may or may not be cancer). The goal is to create a resource for researchers at Wake Forest University Comprehensive Cancer Center to study cancer in the future. Researchers will use these samples to analyze the genetic makeup of tumors and grow living cells for further study. They will also review your medical records to gather information about your diagnosis and treatment. This study is open to adults aged 18 to 120 years who are scheduled for surgery or biopsy for a suspected solid tumor and provide their consent. The main goal is to establish a tissue and cell repository for future research.

Study design
This is an observational study, meaning researchers are collecting information without providing any specific treatment. It plans to enroll up to 20,000 participants.
What's involved
If you participate, tissue and blood samples will be collected during your planned surgery or biopsy. Researchers will also review your medical records.
Compensation
Not stated in the trial record.
Follow-up
Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT00900471

Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors

Recruiting
Not specifiedAges 18+Observational
Wake Forest University Health Sciences
~20,000 participants
Updated 2026-03-19 on ClinicalTrials.gov
What's tested:biologic sample preservation proceduremedical chart review

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Tissue and cell repository for Wake Forest University Comprehensive Cancer Center investigators
Measured over Day 1
Unspecified Adult Solid Tumor, Protocol Specific
Unspecified Childhood Solid Tumor, Protocol Specific

NCT00900471

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Wake Forest University Comprehensive Cancer Center

    Winston-Salem, North Carolinastudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Edward A. Levine, MD · STUDY_CHAIR · Wake Forest University Health Sciences

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Signed protocol specific informed consent prior to registration/randomization.
Clinically suspected solid tumor AND scheduled for surgical resection and/or biopsy
  • Tissue and cell repository for Wake Forest University Comprehensive Cancer Center investigatorsDay 1